|

tirapazamine Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • Zhejiang Raygene Pharmaceuticals Co., Ltd1
  • Teclison Ltd.1

Indications

  • Liver Cancer2
  • Cancer2
  • Liver Disease1
  • Gastrointestinal Cancer Metastatic1
  • HCC1

Other1 trial

A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
Phase 2/3

Palo Alto, California1 trial

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Stanford University

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.